Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07219875 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Training Reward Responsiveness Through Virtual Reality

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jul 8, 2025 to May 21, 2025 Show 4 more changesShow less
    • Eligibility criteria expanded, about 25 words
    • Secondary endpoints: 12 to 6
    • Study description shortened, about 25 words
    • Site contact updated
  2. Interventions: Enhanced Virtual Reality-Reward Training (eVR-RT) (Behavioral), Virtual Reality-Memory Training (VR-MT) (Behavioral) to Virtual Reality-Memory Training (VR-MT) (Behavioral), Virtual Reality-Reward Training (VR-RT) (Behavioral)
    • Study description shortened, about 4 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare the effects of Virtual Reality-Reward Training (VR-RT) with an active control condition, Virtual Reality-Memory Training (VR-MT), on positive affect and other clinical symptoms. VR-RT is a novel intervention aimed at enhancing savoring of positive experiences among individuals with elevated depression and low positive affect through guided imaginal recounting following immersion in positive VR experiences. The current study tests an enhanced version of this training using improved virtual reality technology. Target enrollment is 80 participants with low positive affect, depression, and impaired functioning, who are at least 18 years old, who will be randomly assigned to 4 weeks of either VR-RT or VR-MT. Participants will complete in-person VR sessions, laboratory assessments, and self-report questionnaires as part of the study. The total length of participation is around 3 months.
Trial Details
NCT Number NCT07219875
Lead Sponsor University of California, Los Angeles
Conditions
(from sponsor)		 Positive Affect, Depression
Related terms Depression
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov